1. Camma C, Schepis F, Orlando A, Albanese M, Shahied L, Trevisani F, Andreone P, Craxi A, Cottone M (2002) Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 224: 47–54
2. Fukushima S, Kishimoto S, Hayashi Y, Kaneko M, Nakano M, Shibata J, Fujiyama S, Sato T (1988) Arterial infusion chemotherapy for hepatocellular carcinoma using a suspension of cisplatin in lipiodol (LPS), Part 1. J Jpn Soc Clin Oncol 23: 2743–2749
3. Furue H, Hara Y, Imamura Y, Kimura T, Oyama Y, Kurihara M, Umashima H, Nakao I, Nitani H, Ogawa I, Ooi Y, Saito T, Sakai Y, Sakano T, Sakuma A, Takatani O, Tominaga Y, Yokoyama M (1986) Japanese Society of Clinical Oncology: II. Criteria for evaluation of increased efficacy in solid tumor chemotherapy. J Jpn Soc Clin Oncol 21: 943–953
4. Kanematsu T, Inokuchi K, Sugimachi K, Furuta T, Sonoda T, Tamura S, Hasuo K (1984) Selective effects of lipidiolized anticancer agents. J Surg Oncol 25: 218–226
5. Kishimoto S, Fukui M, Fukushima S, Nakano M (1992) Application of a lipophilic platinum derivative contained in an oily lymphographic agent to intra-hepatic arterial chemotherapy. Reg Cancer Treat 1–2: 25–29